Bangladesh DGHS 2026: measles
Bangladesh national DGHS Bangladesh Current
National Guideline for the Management of Measles
Directorate General of Health Services, Bangladesh. 2026
Summary checked against the source: 2026-11
National guideline for the management of measles, written mainly for children but covering adults, pregnancy and immunocompromised patients. Page numbers are the guideline's printed pages.
At a glance
- Suspect measles: fever + rash + cough, coryza or conjunctivitis. Confirm with measles IgM (ELISA) or RT-PCR on a throat or nasopharyngeal swab or blood. [p. 16]
- Infectious from 4 days before to 4 days after rash onset (longer if immunocompromised): isolate for at least 4 days after the rash. [p. 22]
- Vitamin A for every case, at diagnosis and again after 24 hours (third dose at 2–4 weeks with eye signs or malnutrition). [p. 26]
- Classify as no complications (home), non-severe complications (admit), or severe (tertiary care). [p. 24–25]
- No steroids for measles croup (more immune suppression); no NSAIDs in children. [p. 26, 28]
- Post-exposure: vaccine within 72 hours, or immunoglobulin within 6 days for infants, pregnant women and immunocompromised contacts. [p. 33]
Natural history
| Phase | Features |
|---|---|
| Incubation | 10–14 days (7–23) |
| Prodrome (about 4 days) | High fever, Koplik spots on the buccal mucosa, cough, coryza, conjunctivitis with photophobia; shedding starts |
| Exanthem | Red maculopapular rash on day 4, starting on the forehead and behind the ears, spreading down to the trunk, limbs, then palms and soles |
| Recovery | Rash fades over about 7 days in the same order, leaving fine desquamation |
Adapted from BD-DGHS 2026 [p. 18]
Most deaths come from pneumonia, sepsis, diarrhoea and encephalitis after the first week of rash. Measles causes profound immune suppression ("immune amnesia") and depletes vitamin A (xerophthalmia, keratitis, blindness). [p. 17–18]
High-risk groups: under 5, infants and adults over 20, malnourished, vitamin A deficient, pregnant, immunocompromised (HIV: very prolonged shedding), unvaccinated. [p. 18, 21]
Rashes that mimic measles
| Illness | Clue |
|---|---|
| Dengue | Flushing in the first 2–3 days; "islands of white in a sea of red" in recovery |
| Chickenpox | Vesicular, itchy, lesions at different stages together |
| Fifth disease | "Slapped cheek", spares palms and soles |
| Rubella | Pink macular rash on day 1 of fever, gone by day 3 |
| Meningococcal septicaemia | Tender petechial rash with necrotic centres, very ill |
Adapted from BD-DGHS 2026 [p. 19]
Classification and management
| No complications | Non-severe complications | Severe or complicated | |
|---|---|---|---|
| Features | Alert, feeding well | Diarrhoea with some dehydration; pneumonia with SpO₂ ≥90%; pus from the eyes; ear pain or discharge; mouth ulcers affecting feeding; moderate malnutrition; poor access to follow-up | Can't drink or breastfeed; vomiting ≥3/hour; convulsions; lethargy or unconsciousness; severe respiratory distress; RR >70; SpO₂ <90% or cyanosis; shock; severe acute malnutrition; corneal ulcer or opacity; sepsis; immunocompromised |
| Where | Home, isolated for 4 days | Admit (UHC, district hospital) | Medical college or tertiary hospital |
| Treatment | Vitamin A × 2, paracetamol, fluids, nutrition, eye care, danger-sign counselling | Treat complications; observe at least 48 h | ABC, oxygen (bubble CPAP), IV or NG fluids, antibiotics; monitor with AVPU |
| Escalate | Any danger sign | Any severe feature | HDU/ICU for SpO₂ <90% despite oxygen, low AVPU, shock, multi-organ involvement, encephalitis |
Adapted from BD-DGHS 2026 classification table [p. 24–25]
Supportive care
| Vitamin A | <6 months: 50,000 IU; 6–12 months: 100,000 IU; ≥12 months: 200,000 IU, at diagnosis and after 24 h; third dose at 2–4 weeks for eye involvement, severe malnutrition or vitamin A deficiency |
| Fever | Paracetamol 10–15 mg/kg 6-hourly; tepid sponging; no NSAIDs in children |
| Fluids | ORS for mild–moderate dehydration; IV for shock, severe dehydration or heavy purging (>15 mL/kg/h); cautious in SAM and severe pneumonia (15 mL/kg/h for 2 h, then 5 mL/kg/h for 6–8 h) |
| Mouth | Salt-water rinses, nystatin, riboflavin, gentian violet for ulcers; amoxicillin if superinfected |
| Eyes | Clean outward from the inner canthus; tetracycline or chloramphenicol ointment for pus; urgent ophthalmology and third vitamin A dose for corneal ulcer or opacity; no steroid eye drops |
Adapted from BD-DGHS 2026 [p. 26–27]
Complications
| Complication | Treatment |
|---|---|
| Pneumonia | Oxygen (bubble CPAP from 5 L/min at 5 cm H₂O, or low-flow, or HFNC). Non-severe: amoxicillin 40–50 mg/kg twice daily × 5 days. Severe: ampicillin 50 mg/kg 6-hourly + gentamicin 7.5 mg/kg daily × 5–7 days; add cloxacillin if Staphylococcus suspected; ceftriaxone second line |
| Croup | Nebulised adrenaline 1:1000, 0.5 mL/kg (max 6 mL), oxygen. No steroids |
| Diarrhoea | ORS after each stool (50–100 mL under 2 years, 100–200 mL over 2); zinc 10 mg (<6 months) or 20 mg daily for 10–14 days |
| Otitis media | Amoxicillin 40–50 mg/kg twice daily × 5 days; look for mastoiditis if discharge >14 days |
| Encephalitis | ABC, oxygen, fluids; diazepam 0.5 mg/kg rectally or lorazepam 0.2 mg/kg IV for seizures; check glucose; HDU/ICU |
| Septic shock | Early antibiotics; Hartmann's 20 mL/kg (max 40 mL/kg) rapidly, or 15 mL/kg/h in SAM; stop fluids if pulse and RR rise; inotropes if no response |
Adapted from BD-DGHS 2026 complications table [p. 27–30]
Discharge when afebrile and stable for 24 h, feeding and hydrated, SpO₂ normal on air, complications controlled, the second vitamin A dose given and follow-up arranged. [p. 30]
Refer urgently for rising oxygen need or SpO₂ <90% after the first hour of oxygen, encephalitis or seizures, shock, unresponsive severe dehydration, SAM, corneal ulcer or opacity, pregnancy, or immunocompromise. [p. 31]
Prevention
- Two doses of measles-containing vaccine; one dose fails to protect 10–15%. ≥95% two-dose coverage is needed for elimination. [p. 33]
- Seroconversion is about 85% at 6–8 months, 85–95% at 9 months and ≥95% from 12 months; vaccine before 6 months doesn't work. [p. 33]
- Post-exposure: MMR or measles vaccine within 72 hours for susceptible contacts (not in pregnancy, newborns or the immunocompromised); immunoglobulin within 6 days for young infants, pregnant women and the immunocompromised. [p. 33]
- Deworming after recovery: albendazole 400 mg (200 mg at 1–2 years). [p. 32]
Clinical pearls
- 3 Cs: cough, coryza, conjunctivitis. Koplik spots are pathognomonic, before the rash.
- Rash starts behind the ears on day 4 and spreads downwards.
- Vitamin A: 50,000 / 100,000 / 200,000 IU, twice, 24 h apart.
- Isolate until 4 days after rash onset.
- SSPE is a late complication, years later.
Classes and levels of evidence
DGHS 2026 is a national programme guideline. It gives standard regimens and operational instructions without grading them by class or level of evidence, so citations on this page give only the page number in the original document. Where it follows WHO guidance, the strength of the WHO recommendation isn't restated.